Norland Tells Asharq Al-Awsat that Goodwill of Libyan Leaders to be Tested

US Ambassador and Special Envoy to Libya Richard Norland (US Embassy)
US Ambassador and Special Envoy to Libya Richard Norland (US Embassy)
TT

Norland Tells Asharq Al-Awsat that Goodwill of Libyan Leaders to be Tested

US Ambassador and Special Envoy to Libya Richard Norland (US Embassy)
US Ambassador and Special Envoy to Libya Richard Norland (US Embassy)

The US Ambassador to Libya, Richard Norland, has said that the North African country is now going through a period in which the “goodwill” of its leaders, who claim they are committed to holding elections, will be put to the test.

However, Norland warned that flippant leaders might find a million reasons to delay the vote.

Speaking to Asharq Al-Awsat, Norland said he believes that good leaders would now actively engage in trying to get things back on the right track as soon as possible. He also reiterated US support and said that Washington would continue to coordinate with international partners.

When addressing the reasons behind delaying Libyan elections, Norland said that Libyan politics were complicated and that it is difficult for external observers to pinpoint exact explanations.

Nevertheless, Norland said that “conflicting candidacies” that appeared relatively late in the election process had spurred fears of violence erupting. This, according to Norland, could have been a motive for a temporary halt of elections.

He relayed his belief in the High National Election Commission (HNEC) having been prepared to hold polls on time. But the organizing body had its work disrupted by controversial candidacies.

Unfortunately, some parties were more than happy to seize the opportunity at hand.

The US diplomat considered that Libyan politicians dodged the responsibility of announcing that elections were postponed mainly because they feared the people holding them accountable.

The US decision to back holding elections as scheduled on December 24 was neither naïve nor a misread of Libya’s political and security status quo, stressed Norland, adding that the country’s politicians must share the blame for what happened.

To this day, no serious political figure in Libya wants to be tied to the delayed polls because they know that people want to hold the vote as soon as possible.

The Libyans chose the date of the elections, and the US strongly supported their desire to meet that date, despite flaws in the electoral law, said Norland.

He noted that there was real traction for holding elections, at least until the issue of controversial candidates erupted.

Norland pointed to the HNEC’s technical preparations having been “highly professional and efficient,” and most serious political actors in Libya, at least, had been in favor of holding elections.

On US threats to saboteurs, the ambassador said that sanctions mainly concern personalities rejecting the results of elections and those who practiced violence mongering to obstruct the electoral process.

According to Norland, the matter of sanctions has not been settled yet, and a decision may be taken in this regard later.

Norland also criticized reports saying his country had lost enthusiasm for the electoral process in Libya and allowed its collapse after realizing that results may not lead to the creation of a unified authority with which the US administration can coordinate.

The US has supported the strong desire of the Libyan people to elect a sovereign, united and legitimate government to move the country onto a firm path toward stability and prosperity, asserted Norland.

As for whether postponing elections benefits and reinforces the influence of armed groups in Libya, Norland said that those groups understand that elections are what the majority of Libyans want for their country.

The US envoy considered that there is an opportunity to build on the previous ceasefire and the broad political dialogue conducted over the past year, aiming to return the elections to the right track in a reasonable time.

Free, fair, and inclusive elections can lead to a democratic government that best serves the interests of the Libyan people, asserted Norland.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.